A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
Clinical trial NCT03247686 · COMPLETED
Trial details
- NCT number
- NCT03247686
- Sponsor
- Resolve Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-07-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.